Recruiting
Phase 1
Phase 2

Safety and Effectiveness of the PXL-Platinum 330 System

Sponsor:

Colorado Eye Consultants/Cornea Consultants of Colorado

Code:

NCT04401865

Conditions

Corneal Ectasia

Keratoconus

Pellucid Marginal Corneal Degeneration

Eligibility Criteria

Sex: All

Age: 8+

Healthy Volunteers: Not accepted

Interventions

PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Colorado Eye Consultants/Cornea Consultants of Colorado on 2022-01-25.